Clinical Research & Development and Medical Affairs, OPKO Pharmaceuticals, Miami, FL.
Adv Chronic Kidney Dis. 2018 Nov;25(6):530-534. doi: 10.1053/j.ackd.2018.08.003.
Of late, fewer residents are choosing nephrology as a career. Contributing factors may include lack of prestige, uncertain potential of future income, and poor work-life balance. Some current nephrologists are considering transitioning to another career for similar reasons. For those who decide that practicing nephrology is no longer appealing, there are many available avenues where they can use their nephrology expertise and still have a successful future. A leadership role in the pharmaceutical industry is a potentially attractive and viable option to nephrologists who are ready to transition to a different career. As industry-sponsored clinical trials increase in number, there will be a need for more nephrologists at entry and higher level positions. This in turn will lead to more nephrologists advancing to senior management and who will then be positioned to advocate for further investments in nephrology, thereby opening the door for other nephrologists to join the industry.
最近，选择肾脏病学作为职业的住院医师越来越少。造成这种情况的原因可能包括缺乏威望、未来收入不确定和工作与生活失衡。一些现有的肾脏病医生出于类似的原因也在考虑转行。对于那些认为从事肾脏病学不再有吸引力的人来说，有很多途径可以让他们利用自己的肾脏病学专业知识，并有一个成功的未来。对于那些准备转行的肾脏病医生来说，在制药行业担任领导角色是一个有吸引力和可行的选择。随着行业赞助的临床试验数量的增加，需要更多的肾脏病医生在入门级和更高职位上工作。这反过来又将导致更多的肾脏病医生晋升为高级管理层，然后他们将有机会倡导进一步投资肾脏病学，从而为其他肾脏病医生加入该行业打开大门。
